Cue Biopharma

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cue Biopharma and other ETFs, options, and stocks.

About CUE

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its pipeline includes Immuno-oncology, CUE-100 framework, CUE-200 framework, and autoimmune disease.

CEO

Daniel R. Passeri

CEODaniel R. Passeri

Employees

Employees57

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2014

Founded2014

Employees

Employees57

CUE Key Statistics

Market cap

82.79M

Market cap82.79M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

132.13K

Average volume132.13K

High today

$2.51

High today$2.51

Low today

$2.34

Low today$2.34

Open price

$2.36

Open price$2.36

Volume

25.30K

Volume25.30K

52 Week high

$18.42

52 Week high$18.42

52 Week low

$2.30

52 Week low$2.30

CUE News

Simply Wall St 4d

Despite Lacking Profits Cue Biopharma Seems To Be On Top Of Its Debt - Simply Wall St

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a...

CUE Earnings

-$0.44

-$0.29

-$0.15

$0.00

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 9, After Hours

ActualExpected Nov 9, After Hours